sulbactam has been researched along with Infectious Skin Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adamson, RT; Amara, S; Huang, X; Lew, I | 1 |
Alpert, M; Babinchak, T; Gardiner, D; Matthews, P; McGovern, PC; Pedersen, R; Rahav, G; Rill, D; Zito, E | 1 |
Deguchi, K; Fukayama, S; Fukushima, Y; Koguchi, M; Nakane, Y; Nishimura, Y; Oda, S; Sato, K; Tanaka, S; Yokota, N | 1 |
Aronoff, SC; Blumer, JL; Goldfarb, J; Jaffe, A; Reed, MD | 1 |
2 trial(s) available for sulbactam and Infectious Skin Diseases
Article | Year |
---|---|
A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Female; Humans; Male; Middle Aged; Minocycline; Skin Diseases, Bacterial; Skin Diseases, Infectious; Sulbactam; Tigecycline | 2012 |
Sultamicillin in the treatment of superficial skin and soft tissue infections in children.
Topics: Abscess; Ampicillin; Child; Child, Preschool; Cloxacillin; Diarrhea; Drug Combinations; Drug Evaluation; Female; Folliculitis; Humans; Infant; Male; Penicillanic Acid; Random Allocation; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcal Skin Infections; Streptococcal Infections; Sulbactam | 1987 |
2 other study(ies) available for sulbactam and Infectious Skin Diseases
Article | Year |
---|---|
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Cefazolin; Female; Hospitalization; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Skin Diseases, Bacterial; Skin Diseases, Infectious; Sulbactam; Treatment Outcome; Vancomycin | 2013 |
[Antimicrobial activity of cefteram comparison with other oral antibiotics].
Topics: Ampicillin; Bacteria; Cefmenoxime; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Methicillin; Penicillin Resistance; Respiratory Tract Infections; Skin Diseases, Infectious; Staphylococcus aureus; Sulbactam; Urinary Tract Infections | 1989 |